Inhibition of Escherichia coli-Induced Meningitis by Carboxyfullerence

ABSTRACT The effect of a water-soluble malonic acid derivative of carboxyfullerence (C60) against Escherichia coli-induced meningitis was tested. C60 can protect the mice from E. coli-induced death in a dose-dependent manner. C60 administered intraperitoneally as late as 9 h after E. coliinjection was still protective. The C60-treated mice had less tumor necrosis factor alpha and interleukin-1β production by staining of brain tissue compared to the levels of production for nontreated mice. The E. coli-induced increases in blood-brain barrier permeability and inflammatory neutrophilic infiltration were also inhibited. These data suggest that C60 is a potentially therapeutic agent for bacterial meningitis.

[1]  A. Cross,et al.  Blood–Brain Barrier Permeability during the Development of Experimental Bacterial Meningitis in the Rat , 1997, Experimental Neurology.

[2]  L. Chiang,et al.  Multi-hydroxy additions onto C60 fullerene molecules , 1992 .

[3]  W. Krätschmer,et al.  Solid C60: a new form of carbon , 1990, Nature.

[4]  S. Han,et al.  Apoptotic signal of Fas is not mediated by ceramide. , 1998, Blood.

[5]  K. Preston,et al.  Radical Reactions of C60 , 1991, Science.

[6]  V. Perry,et al.  The blood-brain barrier and the inflammatory response. , 1997, Molecular medicine today.

[7]  V. Quagliarello,et al.  Treatment of bacterial meningitis , 1999, Comprehensive therapy.

[8]  E. Nakamura,et al.  In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. , 1995, Chemistry & biology.

[9]  Shen,et al.  Carboxyfullerenes as neuroprotective agents. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Brandtzaeg,et al.  Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response , 1989, The Journal of experimental medicine.

[11]  L. López-Cortés,et al.  Measurement of Levels of Tumor Necrosis Factor-α and Interleukin-1β in the CSF of Patients with Meningitis of Different Etiologies: Utility in the Differential Diagnosis , 1993 .

[12]  E. Benveniste.  Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. , 1992, The American journal of physiology.

[13]  R. van Furth,et al.  Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy , 1996, Infection and immunity.

[14]  L. Chiang,et al.  Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C60. , 1997, Toxicology letters.

[15]  E. Thompson,et al.  Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta. , 1992, The Journal of infectious diseases.

[16]  R. Zinkernagel,et al.  Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients , 1988, The Journal of experimental medicine.

[17]  A. Cerami,et al.  The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis , 1990, The Journal of experimental medicine.

[18]  D. Choi,et al.  Buckminsterfullerenol Free Radical Scavengers Reduce Excitotoxic and Apoptotic Death of Cultured Cortical Neurons , 1996, Neurobiology of Disease.

[19]  E. Thompson,et al.  Blood-Brain Barrier Damage in Patients with Bacterial Meningitis: Association with Tumor Necrosis Factor-α but not Interleukin-Iβ , 1992 .

[20]  O. Ramilo,et al.  Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation , 1990, The Journal of experimental medicine.

[21]  H. Lei,et al.  Infiltrated Cells in Experimental Allergic Encephalomyelitis by Additional Intracerebral Injection in Myelin-Basic-Protein-SensitizedB6 Mice. , 1997, Journal of biomedical science.

[22]  L. Chiang,et al.  Versatile nitronium chemistry for C60 fullerene functionalization , 1992 .

[23]  T. Tsuchiya,et al.  Novel harmful effects of [60]fullerene on mouse embryos in vitro and in vivo , 1996, FEBS letters.

[24]  R. Janzer,et al.  Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.

[25]  T. Mashino,et al.  Inhibitory effect of a fullerene derivative, monomalonic acid C60, on nitric oxide-dependent relaxation of aortic smooth muscle. , 1997, General pharmacology.

[26]  O. Ramilo,et al.  Role of tumor necrosis factor alpha (cachectin) in experimental and clinical bacterial meningitis. , 1989, The Pediatric infectious disease journal.

[27]  C. Chou,et al.  Blockage of apoptotic signaling of transforming growth factor-beta in human hepatoma cells by carboxyfullerene. , 1998, European journal of biochemistry.

[28]  I. Romero,et al.  Transporting therapeutics across the blood-brain barrier. , 1996, Molecular medicine today.

[29]  Y. S. Lin,et al.  Sepsis-induced apoptosis of the thymocytes in mice. , 1994, Journal of immunology.

[30]  W. Scheld,et al.  Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. , 1991, The Journal of clinical investigation.

[31]  T. Luh,et al.  Carboxyfullerene Prevents Iron‐Induced Oxidative Stress in Rat Brain , 1999, Journal of neurochemistry.

[32]  L. López-Cortés,et al.  Measurement of levels of tumor necrosis factor-alpha and interleukin-1 beta in the CSF of patients with meningitis of different etiologies: utility in the differential diagnosis. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  F. Wudl,et al.  Pharmacokinetics of a water-soluble fullerene in rats , 1996, Antimicrobial agents and chemotherapy.

[34]  C. Smith,et al.  Mechanisms of neutrophil‐induced parenchymal cell injury , 1997, Journal of leukocyte biology.

[35]  L. Chiang,et al.  Acute and Subacute Toxicity Study of Water-Soluble Polyalkylsulfonated C60 in Rats , 1998, Toxicologic pathology.